KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Gross Margin (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Gross Margin for 11 consecutive years, with 8145.5% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 810371.0% to 8145.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 54.59% through Dec 2025, up 1677.0% year-over-year, with the annual reading at 40.56% for FY2025, 274.0% up from the prior year.
  • Gross Margin hit 8145.5% in Q4 2025 for Fulgent Genetics, up from 42.24% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 8145.5% in Q4 2025 to a low of 28.43% in Q1 2023.
  • Historically, Gross Margin has averaged 476.02% across 5 years, with a median of 42.24% in 2025.
  • Biggest five-year swings in Gross Margin: tumbled -4730bps in 2023 and later surged 810371bps in 2025.
  • Year by year, Gross Margin stood at 75.31% in 2021, then plummeted by -42bps to 43.63% in 2022, then fell by -18bps to 35.78% in 2023, then increased by 17bps to 41.79% in 2024, then surged by 19392bps to 8145.5% in 2025.
  • Business Quant data shows Gross Margin for FLGT at 8145.5% in Q4 2025, 42.24% in Q3 2025, and 42.1% in Q2 2025.